bpc-157 clinical trials safety efficacy studies Here's a nice graphic on that you can hand out to patients who inquire about it. Thanks to Chris Centeno, M.D bpc-157 clinical trial humans safety – What is BPC-157? | Everything

And many symptoms overlap with other conditions

[PubMed] [Google Scholar] Joshi S, Cauch-Dudek K, Heathcote EJ, Lindor K, Jorgensen R, Klein R

24 h 250 mg, 2h recovery Von Clarmann (1987)

Separate Choice from Licensure: A patient may legally possess a substance that a physician cannot legally prescribe or administer

On a similar note, men with higher than average body fat are more affected by alcohol than those with lower body fat percentages and the same weight

BPC-157 has been studied for its potential interaction with nitric oxide synthase activity and vascular endothelial growth factor (VEGF) signaling, which regulate tissue organization and endothelial function through gene expression modulation rather than direct receptor activation